Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2388
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG:
Olopatadine Hydrochloride Nasal Spray 0.6%
DRUG:
Vehicle
Sponsor
Alcon Research